Skip to main content
. 2021 May 21;9(6):541. doi: 10.3390/vaccines9060541

Figure 1.

Figure 1

Anti-SARS-CoV-2 antibody levels among volunteers. (a) The total levels of anti-SARS-CoV-2 phosphorylated nucleoprotein (PNC) and anti-SARS-CoV-2 spike (S) antibodies among study participants (N = 14). (b) The changes in the anti-SARS-CoV-2 PNC (left) and anti-SARS-CoV-2 S (right) antibody levels within 10 weeks in five study participants. Each dot represents a single study participant.